Active Pharmaceutical Ingredients - Dr Reddy's
Active Pharmaceutical Ingredients - Dr Reddy's

关于 Acalabrutinib API

Product
  • 治疗类别 抗癌/抗肿瘤

  • CAS 编号

    870524-78-5

  • API 技术

    Small molecule

  • 剂型

    口服固体/胶囊

  • Dr Reddy's 开发状态

    开发中

Mechanism of Action

Acalabrutinib is a Bruton tyrosine kinase (BTK) inhibitor. BTK is a protein that plays an important role in the survival and growth of B cells. By blocking BTK, acalabrutinib can help to slow down or even stop the growth of cancer cells.

Indication

The FDA approved Acalabrutinib for the treatment of adult patients with Mantle Cell Lymphoma (MCL) has received at least one prior therapy. Chronic lymphocytic leukemia (CLL). Small lymphocytic lymphoma (SLL).

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Country *
Select Product *
Select Regulatory Requirements
Select Purpose

Related APIs

Bortezomib(硼替佐米)

抗癌/抗肿瘤

arrow

Cabazitaxel(卡巴他赛)

抗癌/抗肿瘤

arrow

Cabozantinib S‑Malate(苹果酸卡博替尼)

抗癌/抗肿瘤

arrow

Capecitabine(卡培他滨)

抗癌/抗肿瘤

arrow

Carfilzomib(卡非佐米)

抗癌/抗肿瘤

arrow

Decitabine(地西他滨)

抗癌/抗肿瘤

arrow

Deucravacitinib(‌氘可来昔替尼)

抗癌/抗肿瘤

arrow

Enzalutamide(恩扎卢胺)

抗癌/抗肿瘤

arrow

Eribulin Mesylate(甲磺酸艾立布林)

抗癌/抗肿瘤

arrow

Gemcitabine Hydrochloride(盐酸吉西他滨)

抗癌/抗肿瘤

arrow

Granisetron(格拉司琼)

抗癌/抗肿瘤

arrow

Midostaurin (Amorphous and Form II)(米哚妥林,无定形及 II 晶型)

抗癌/抗肿瘤

arrow

Pazopanib(帕唑帕尼)

抗癌/抗肿瘤

arrow

Pomalidomide(泊马度胺)

抗癌/抗肿瘤

arrow

Relugolix(瑞卢戈利)

抗癌/抗肿瘤

arrow

Ripretinib(瑞派替尼)

抗癌/抗肿瘤

arrow

Tucatinib(图卡替尼)

抗癌/抗肿瘤

arrow

Venetoclax(维奈托克)

抗癌/抗肿瘤

arrow

Zoledronic Acid(唑来膦酸)

抗癌/抗肿瘤

arrow

Acalabrutinib(阿卡替尼)

抗癌/抗肿瘤

arrow

Adagrasib(阿达格拉西布)

抗癌/抗肿瘤

arrow

Fruquintinib(呋喹替尼)

抗癌/抗肿瘤

arrow

Pirtobrutinib(匹妥布替尼)

抗癌/抗肿瘤

arrow

Olaparib (Form A)(奥拉帕利,A 晶型)

抗癌/抗肿瘤

arrow

Palbociclib(哌柏西利)

抗癌/抗肿瘤

arrow

Pemetrexed Disodium Heptahydrate(培美曲塞二钠七水合物)

抗癌/抗肿瘤

arrow

Abiraterone Acetate(醋酸阿比特龙)

抗癌/抗肿瘤

arrow

Apalutamide (Amorphous and Form B)(阿帕他胺,无定形及 B晶 型)

抗癌/抗肿瘤

arrow

Zanubrutinib(泽布替尼)

抗癌/抗肿瘤

arrow

Azacitidine(阿扎胞苷)

抗癌/抗肿瘤

arrow

Nilotinib Hydrochloride(盐酸尼洛替尼)

抗癌/抗肿瘤

arrow

Lenalidomide (Form A)(来那度胺,A 晶型)

抗癌/抗肿瘤

arrow

Lomustine(洛莫司汀)

抗癌/抗肿瘤

arrow

Lenvatinib Mesylate (Form C and MIBK Solvate)(甲磺酸仑伐替尼,C 型及 MIBK 溶合物)

抗癌/抗肿瘤

arrow

Lenvatinib Mesylate (Form-C) 甲磺酸仑伐替尼(晶型 C及)

抗癌/抗肿瘤

arrow

Cabozantinib Hydrochloride(盐酸卡博替尼)

抗癌/抗肿瘤

arrow

Dasatinib Monohydrate(达沙替尼一水合物)

抗癌/抗肿瘤

arrow

Bendamustine Hydrochloride(盐酸苯达莫司汀)

抗癌/抗肿瘤

arrow

免责声明

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.